Sulfonated Calpeptine is a promising drug candidate against SARS-CoV2 infections
DESY Publication Database (PUBDB) (Deutsches Elektronen-Synchrotron) · 01.01.2023
DOI: 10.3204/pubdb-2022-01607 ↗Kurz gefasst
Fachartikel in der Zeitschrift DESY Publication Database (PUBDB) (Deutsches Elektronen-Synchrotron), erschienen am 01.01.2023. Verfasst von Patrick Y. A. Reinke und 49 weiteren Autor:innen.
Abstract (Originalsprache)
Several drug screening campaigns identified Calpeptin as a drug candidate against SARS-CoV-2. Initially reported to target the viral main protease (Mpro), its moderate activity in M$^{pro}$ inhibition assays hints at a second target. Indeed, we show that Calpeptin is an extremely potent cysteine cathepsin inhibitor, a finding additionally supported by X-ray crystallography. Cell infection assays proved Calpeptin’s efficacy against SARS-CoV-2. Treatment of SARS-CoV-2-infected Golden Syrian hamsters with sulfonated Calpeptin at a dose of 1 mg/kg body weight reduces the viral load in the trachea. Despite a higher risk of side effects, an intrinsic advantage in targeting host proteins is their mutational stability in contrast to highly mutable viral targets. Here we show that the inhibition of cathepsins, a protein family of the host organism, by calpeptin is a promising approach for the treatment of SARS-CoV-2 and potentially other viral infections.
Schlagwörter
Zitieren
APA
Reinke, P. Y. A., Souza, D., Elisa, E., Günther, S., Falke, S., Lieske, J., Ewert, W., Loboda, J., Herrmann, A., Mashhour, R., Aida, Karničar, K., Usenik, A., Lindič, N., Sekirnik, A., Botosso, V. F., Santelli, Machado, G. M., Kapronezai, J., …, & Dusan (2023). Sulfonated Calpeptine is a promising drug candidate against SARS-CoV2 infections. DESY Publication Database (PUBDB) (Deutsches Elektronen-Synchrotron). https://doi.org/10.3204/pubdb-2022-01607
Vancouver
Reinke PYA, Souza D, Elisa E, Günther S, Falke S, Lieske J, et al. Sulfonated Calpeptine is a promising drug candidate against SARS-CoV2 infections. DESY Publication Database (PUBDB) (Deutsches Elektronen-Synchrotron). 2023. doi:10.3204/pubdb-2022-01607
BibTeX
@article{Reinke2023,
author = {Reinke, Patrick Y. A. and Souza, de and Elisa, Edmarcia and Günther, Sebastian and Falke, Sven and Lieske, Julia and Ewert, Wiebke and Loboda, Jure and Herrmann, Alexander and Mashhour, Rahmani and Aida and Karničar, Katarina and Usenik, Aleksandra and Lindič, Nataša and Sekirnik, Andreja and Botosso, Viviane Fongaro and Santelli and Machado, Gláucia Maria and Kapronezai, Josana and Araújo, de and Valdemir, Marcelo and Silva‐Pereira, Taiana Tainá and Filho, Antônio Francisco de Souza and Tavares, Mariana Silva and Flórez‐Álvarez, Lizdany and Oliveira, de and Leal, Danielle Bruna and Durigon, Edison Luíz and Giaretta, Paula Roberta and Heinemann, Marcos Bryan and Hauser, Maurice and Seychell, Brandon Charles and Böhler, Hendrik and Rut, Wioletta and Drąg, Marcin and Beck, Tobias and Cox and Russell and Chapman, Henry N. and Betzel and Christian and Brehm, W. and Hinrichs, Winfried and Ebert, Gregor and Latham and L., Sharissa and Guimarães and Sá, Ana Marcia de and Turk and Dusan},
title = {Sulfonated Calpeptine is a promising drug candidate against SARS-CoV2 infections},
journal = {DESY Publication Database (PUBDB) (Deutsches Elektronen-Synchrotron)},
year = {2023},
doi = {10.3204/pubdb-2022-01607}
}
EUVIMED